.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Julphar
Covington
McKesson
Harvard Business School
Express Scripts
Fish and Richardson
McKinsey
QuintilesIMS
Citi

Generated: June 24, 2017

DrugPatentWatch Database Preview

CAPITROL Drug Profile

« Back to Dashboard

Which patents cover Capitrol, and what generic Capitrol alternatives are available?

Capitrol is a drug marketed by Westwood Squibb and is included in one NDA.

The generic ingredient in CAPITROL is chloroxine. Additional details are available on the chloroxine profile page.

Summary for Tradename: CAPITROL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list87
Patent Applications: see list493
Drug Prices:see details
DailyMed Link:CAPITROL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westwood Squibb
CAPITROL
chloroxine
SHAMPOO;TOPICAL017594-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CAPITROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Westwood Squibb
CAPITROL
chloroxine
SHAMPOO;TOPICAL017594-001Approved Prior to Jan 1, 19823,886,277► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Healthtrust
Harvard Business School
Citi
Baxter
Deloitte
US Department of Justice
McKinsey
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot